Welcome to CDC Stacks | Treatment options for latent tuberculosis infection - 22026 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Treatment options for latent tuberculosis infection
  • Published Date:
    November 2011
  • Source:
    TB elimination
  • Language:
    English
Filetype[PDF - 195.72 KB]


Details:
  • Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
  • Keywords:
  • Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. Certain groups are at very high risk of developing TB disease once infected. Once the diagnosis of LTBI has been made, health care providers must choose the most appropriate and effective treatment regimen, and make every effort to ensure those persons complete the entire course of treatment for LTBI.

    However, if exposed to and infected by a person with multidrug-resistant TB (MDR TB) or extensively drug-resistant TB (XDR TB), preventive treatment may not be an option.

  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Treatment options for latent tuberculosis infection
    Corporate Author:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    August 2016
    Series:
    TB elimination
    Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating : TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. The Centers for Disease Control and...
    File Type:
    Filetype[PDF - 1.30 MB]
  2. Improving treatment completion for latent tuberculosis infection among health care workers
    Personal Author:
    Coley, Joan
    Corporate Author:
    Harlem Hospital (New York, N.Y.); New York (N.Y.), Dept. of Health.; Columbia University; Harlem Hospital Center (New York, N.Y.); Centers for Disease Control and Prevention (U.S.);
    Published:
    1999
    Description:
    Charles P. Felt National Tuberculosis Center at Harlem Hospital. : "The Charles P. Felton National Tuberculosis Center is a joint project of Harlem Hospital, Columbia University, Health & Hospitals Corporation, and the New York City Department of Hea...
    File Type:
    Filetype[PDF - 524.72 KB]
  3. Treatment of latent tuberculosis infection and tuberculosis disease
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    2016
    Series:
    Self-study modules on tuberculosis ; module 4
    Description:
    In this module, you will learn about the principles of treating latent TB infection (LTBI) and TB disease. A person with LTBI is treated to prevent them from progressing to TB disease. Some people with LTBI are at very high risk of developing TB dise...
    File Type:
    Filetype[PDF - 2.73 MB]
  4. Treatment of latent tuberculosis infection and tuberculosis disease
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    2008
    Series:
    Self-study modules on tuberculosis ; module 4
    Description:
    The Self-Study Modules on Tuberculosis are a series of educational modules designed to provide information about TB in a self-study format. The series consists of a total of nine modules that are separated into two courses. The first course, Modules ...
    File Type:
    Filetype[PDF - 829.72 KB]
  5. Targeted tuberculin testing and treatment of latent tuberculosis infection
    Corporate Author:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.; American Thoracic Society; Centers for Disease Control and Prevention (U.S.);
    Published:
    June 9, 2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-6):1-51.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. SS-6
    American journal of respiratory and critical care medicine ; v. 161, no. 4, pt. 2, p. 221-247
    Description:
    "This statement provides new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI) and updates previously published guidelines. This statement is issued in recognition of the impo...
    Status:
    current
    File Type:
    Filetype[PDF - 350.39 KB]